Original Source(s)
Related Content
FDA adds generic valganciclovir oral solution
The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.
by Mouj Hijazi
October 28, 2026
-
2 min
FDA clears at-home risankizumab induction
Week 12 remission reached 56% vs. 30% with placebo, with the FDA revising tuberculosis testing precautions.
by Teraya Smith
October 23, 2026
-
2 min
Medical Oddities: The ghost that haunted a heart
From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.
by Teraya Smith
October 29, 2026
-
6 min
